Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis

NCT06022874 is registered in ClinicalTrials.gov with Phoilex Ltd. as lead sponsor.

NCT NCT06022874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06022874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis
Lead sponsor
Phoilex Ltd.
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2023
Completion date
October 30, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis